News | February 15, 2022
Launches and margin sustainability hold key for Glenmark: ICICI Direct
Key takeaways of Q3FY22 quarter & conference call highlights
Key takeaways of Q3FY22 quarter & conference call highlights
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
The Vasostrict brand market had U.S. sales of approximately US $ 878.5 million MAT for the most recent twelve months ending in December 2021 according to IQVIA Health
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
It has a total of 50 ANDA approvals from USFDA
Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy
It would be the first protein-based alternative available in Israel
Potassium chloride is used to prevent or to treat low blood levels of potassium
Glenmark’s current portfolio consists of 173 products authorized for distribution in the U.S. marketplace and 46 ANDA’s pending approval with the U.S. FDA
Subscribe To Our Newsletter & Stay Updated
